can you become immune to tirzepatide for Weight Loss & Diabetes Does Your Body Get Used

Patients with suboptimal weight loss [56] or non-remission of T2D [57] after RYGB had attenuated post-prandial GLP-1 response, which raised the possibility of using GLP-1 receptor agonists (GLP-1 RA) to treat residual diabetes or diabetes relapse

Refine Your Confidence

We'll help you answer the question: Is it worth trying in 2025

Declarations Ethics approval and consent to participate: Not applicable since this study was based on publicly available anonymous data from the FDA Adverse Event Reporting System database

Key takeaways Blood clots are not a known result of Ozempic use

Zepbound is unique because it acts on two gut hormones (GLP-1 and GIP), offering additional benefits